ArticleOphthalmology science2026
Federated Learning for Multi-Disease Ophthalmic Diagnostics Using OCT Angiography.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Federated Machine Learning Approach for the Detection and Visualisation of Eye Diseases Using Activation Maps.Sensors (Basel, Switzerland) · 2026Article
- Federated learning for privacy-preserving ophthalmic artificial intelligence: clinical applications and translational challenges.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose: To conduct a comprehensive systematic evaluation of federated learning (FL) strategies for multi-disease retinal classification using OCT angiography (OCTA), implementing a 2-part experimental framework to establish foundational feasibility and optimize performance under realistic heterogeneous conditions while ensuring privacy preservation. Design: Retrospective multi-center FL study using a systematic 2-part experimental design: (1) foundational feasibility evaluation under controlled homogeneous conditions, and (2) comprehensive optimization under realistic heterogeneous conditions using Dirichlet distribution partitioning ( Participants: A total of 456 OCTA images from patients with 7 retinal pathologies, with diabetic retinopathy (31.1%) and normal cases (25.2%) comprising the majority, sourced from the public OCTA-500 data set (n = 300) and a private collection from the University of Illinois Chicago (n = 156). Methods: Five FL aggregation strategies (federated averaging [FedAvg], federated proximal [FedProx], federated magnetic resonance imaging [FedMRI], federated Adagrad, and federated Yogi) were systematically evaluated across multiple optimization dimensions: 7 architecture configurations spanning vision transformers, established convolutional neural networks, and hybrid models; 5 transfer learning freezing strategies; 3 local epoch configurations (2, 5, and 10); and scalability analysis across 2, 3, and 5-client federations. Security mechanisms including differential privacy (ε = 1.0-8.0) and secure aggregation were integrated and evaluated. Performance was assessed across 3 classification scenarios: 7-class, 4-class modified, and 4-class streamlined. Main Outcome Measures: Classification accuracy, receiver-operating-characteristic area under the curve (ROC-AUC), and macro-averaged F1-score with comprehensive privacy-utility analysis and computational efficiency metrics. Results: Under controlled conditions, FL achieved superior performance in simplified classifications, with FedAvg, FedProx, and FedMRI reaching 72.09% accuracy versus 69.77% centralized training. Comprehensive optimization identified DenseNet121 as optimal architecture (79.55% accuracy, 89.68% ROC-AUC), with "most" freezing strategy (75% frozen layers) providing 60% training time reduction while maintaining superior performance. Federated proximal demonstrated exceptional resilience to heterogeneity (-11.7% degradation). Bonawitz secure aggregation achieved optimal privacy-utility balance (63.64% accuracy with cryptographic guarantees), whereas differential privacy maintained clinical utility under moderate constraints (ε ≈ 4-6). Conclusions: This systematic evaluation establishes FL as a comprehensive solution for privacy-preserving multi-institutional OCTA-based disease classification, with careful architectural selection, optimization strategies, and security mechanisms enabling performance that matches or exceeds centralized approaches while maintaining regulatory compliance and clinical utility. Financial Disclosures: The authors have no proprietary or commercial interest in any materials discussed in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.